Drug Type Antibody |
Synonyms- |
Target |
Mechanism Smad proteins inhibitors(SMAD inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization ![]() |
Active Organization ![]() |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetes Mellitus | Preclinical | ES | ![]() | 01 Nov 2024 |
Obesity | Preclinical | ES | ![]() | 01 Nov 2024 |